Pit AwarenessMonth gif

 

Corcept Therapeutics announces the Grace Study for Cushing

 

Corcept colorlogo jpegThe purpose of the Grace Study is to evaluate the effectiveness (benefits) and safety (side effects) of an investigational study medicine, relacorilant, in treating participants with endogenous Cushing syndrome, also known as hypercortisolism. All eligible participants will receive the investigational study medicine.

READ MORE>

To download the PDF Brochure       CLICK HERE.

Print

Advisory for Adrenal Insufficiency Patients during Covid-19 Outbreak

FleseriuAdvisory for Adrenal Insufficiency Patients during Covid-19 Outbreak

Hello PNA warriors! Due to the Covid-19 outbreak, we have received many inquiries from concerned patients and their loved ones regarding patients with primary or secondary adrenal insufficiency. With little clinical information on the effects the virus has on this patient community, we decided to reach out to one of PNA's trusted neuroendocrine specialist members Maria Fleseriu, MD, FACE for some practical guidance. Thank you so much Dr. Fleseriu for providing this information for us to share with our patient community!

“What I Advise Our Patients for Primary and Secondary Adrenal Insufficiency"

Continue Reading

Print

Coronavirus Pandemic: The PNA is here for you!

beautiful blooming blossom blur 298246

In these unprecedented times of insecurity, we wanted to assure you that we are still here working to provide resources to pituitary patients. Below is a list of just some of the programs and services that we will continue to provide to help pituitary patients and their families gain knowledge about pituitary disorders during these uncertain times:

Continue Reading

Print

No Disruption in Supply as Recordati Takes Over Sales of Signifor

The Cushing’s drugs Signofor and Signifor LAR are now going to be marketed in the U.S. by Recordati, which purchased the rights from Novartis last year. The company says there will be no disruption in supply and the new company will offer a program to subsidize the drugs for low-income families. Read the article here: https://cushingsdiseasenews.com/2020/03/03/recordati-rare-diseases-will-market-signifor-signifor-lar-in-u-s/

Print

More Articles ...

Available Now!

PPRG6-500 Cover
The Pituitary Patient Resource Guide Sixth Edition is now available! Be one of the first to have the most up-to-date information. The Pituitary Patient Resource Guide a one of a kind publication intended as an invaluable source of information not only for patients but also their families, physicians, and all health care providers. It contains information on symptoms, proper testing, how to get a diagnosis, and the treatment options that are available. It also includes Pituitary Network Association's patient resource listings for expert medical care.

Buy Now

Continuing Education Program

Knowledge Icon 500

If you are a nurse or medical professional, register for PNA CEU Membership and  earn CEU credits to learn about the symptoms, diagnosis and treatment options for patients with pituitary disorders. Help PNA reduce the time it takes for patients to get an accurate diagnosis.

button registerNow

For more information click here!